Effect of ciprofloxacin and chloramphenicol on humoral immune response elicited by bovine albumin encapsulated in niosomes

Yaoxue Xuebao

Volumn 42, Issue 8, 2007, Pages 905-910

  Madan, Jitender ^a   Kaushik, Dinesh ^a   Sardana, Satish ^a   Mishra, Dn ^b  

^a Hindu College   (India)

^b GURU JAMBHESHWAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

Author keywords

Chloramphenicol; Ciprofloxacin; IgG antibody; Immunity; Niosomes

Indexed keywords

BOVINE SERUM ALBUMIN; CHLORAMPHENICOL; CIPROFLOXACIN; DRUG CARRIER; HEXOSE; IMMUNOGLOBULIN G; LIPOSOME; SORBITAN OLEATE; SORBITAN TRIOLEATE;

ANIMAL; ANTIBODY PRODUCTION; ARTICLE; BLOOD; DRUG EFFECT; MALE; PARTICLE SIZE; RAT; WISTAR RAT;

ANIMALS; ANTIBODY FORMATION; CHLORAMPHENICOL; CIPROFLOXACIN; DRUG CARRIERS; HEXOSES; IMMUNOGLOBULIN G; LIPOSOMES; MALE; PARTICLE SIZE; RATS; RATS, WISTAR; SERUM ALBUMIN, BOVINE;

EID: 42149183646     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Rang HP, Dale MM, Ritter JM, et al. Pharmacology [M]. 5th ed. England: Churchill Living Stone Publications, 2003:257.
2. Labro MT. Interferences of antibacterial agents with phagocytic functions: immunomodulation or immunofairy tales [J]. Clin Microbiol Rev, 2000, 13:615-650.
3. Villa ML, Rappocciolo G, Piazza P, et al. The interference of antibiotics with antigen specific antibody response in man [J]. Int J Immunopharmacol, 1986, 8:805-809.
4. Bellatisene A, Forsgren A. Effect of doxycycline on immune response in mice [J]. Infect Immun, 1985, 48:556-559.
5. Voiculescu C, Stanciu L, Voiculescu M, et al. Experimental study of antibiotic induced immunosuppression in mice. 1. Humoral and cell-mediated immune responsiveness related to in vivo antibiotic treatment [J]. Comp Immunol Microbiol Infect Dis, 1983, 6:291-299.
6. Lee MH, Kataoka T, Hanjo N, et al. In vivo rapid reduction of alloantigen-activated CD8 + mature cytotoxic T cells by inhibitors of acidification of intracellular organells, prodigiosin 25-C and Concanamycin B [J]. Immunology, 2000, 99:243-248.
7. Daltioff A. Interaction of quinolones with host parasite relationship [M] // Kutilmann J, Daltioff A, Zeiler HJ. Handbook of Experimental Pharmacology. Berlin; Springer Verlog, 1998: 233-257.
8. Nau R, Eiffert H. Modulation of the release of pro-inflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis [J]. Clin Microbiol Rev, 2002, 15:95-110.
9. Edlund C, Nord CE. Effect of quinolones on intestinal ecology [J]. Drugs, 1999, 58(suppl 2):65-70.
10. Schubert S, Ullman U. Effect of antibiotics on chemotaxis, phagocytosis of polymorphonuclear leucocytes and lymphocytes transformation with special reference to modern beta-lactams and fluoroquinolones [M] // Ullman U, Dalhoff A. Significance of Cytokines in the Treatment of Infectious Diseases, Frankfurt /Main; Fischer, 1993: 111-136.
11. Tulkens PM. Intracellular distribution and activity of antibiotics [J]. Eur J Clin Microbiol Infect Dis, 1991, 10:100-106.
12. Neftel KA, Muller MR, Widmer U, et al. Beta-lactam antibiotics inhibit human in vitro gramulopoiesis and proliferation of some other cell types [J]. Cell Biol Toxicol, 1986, 2:513-521.
13. Lubran MM. Hematologic side effects of drugs [J]. Am Clin Lab Sci, 1989, 19:114-121.
14. Carlier MB, Scornneaux B, Zenebergh A, et al. Cellular uptake, localization and activity of fluoroquinolonesin uninfected and infected macrophages [J]. J Antimicrob Chemother, 1990, 26(Suppl):27-39.
15. Tulkens PM. Intracellular pharmacokinetics and localization of antibiotics as predictors of their efficacy against intraphagocytic infections [J]. Scand J Infect Dis, 1991, 74:209-217.
16. Allison AC, Gregoriadis G. Vaccine: recent trends and progress [J]. Immunol Today, 1990, 11:427-429.
17. Gregoriadis G, McCormack B, Obrenovic M, et al. Vaccine entrapment in liposomes [J]. Methods, 1999, 19:156-162.
18. Fortin A, Therien HM. Mechanism of liposome adjuvanticity: an in vivo approach [J]. Immunobiology, 1993, 188:316-322.
19. Vyas SP, Khar RK. Targeted and controlled drug delivery [M]//Niosomes. New Delhi; CBS Publishers and Distributors, 2001:249-250.
20. Brewer JM, Alexander J. The adjuvant activity of nonionic surfactant vesicles (niosomes) on the BALB/c humoral response to bovine serum albumin [J]. Immunology, 1992, 75:570-575.
21. Barry M, Patterson JE, Tirrell S, et al. The effect of chloroquine prophylaxis on yellow fever vaccine antibody response: comparison of plaque reduction neutralization test and enzyme linked immunosorbent assay [J]. Int J Trop Med Hyg, 1991, 44:79-82.
22. Sazoka FC, Paphadjopoulas D. Procedure for the preparation of liposomes with large aqueous space and high captures by reverse phase evaporation method [J]. Proc Natl Acad Sci USA, 1978, 75:4194-4198.
23. Fry DW, White JC, Goldman ID. Rapid separation of low molecular weight solute from liposomes without dilution [J]. Anal Biochem, 1978, 90:809-815.
24. Kruger NJ. The Bradford method for protein quantitation [M]//Walker JM. The Protein Protocols Handbook. New Jersey: Human Press, 15-20.
25. Cevc G, Blume G, Schatzlein A et al. The skin: a pathway for systemic treatment with patches and lipid based agent carriers [J]. Adv Drug Del Rev, 1996, 18:349-378.
26. New RRC. Introduction and preparation of liposomes [M]//New RRC, Liposomes; A Practical Approach. Oxford: Oxford University Press, 1990: 1-104.
27. Zakrevskii VI, Plekhanova NG, Smirnova VI. Entrapping of hydrophobized plague capsular antigen in to large unilamellar liposomes [J]. UKr BioKhim Zh, 1989, 61:89-93.
28. Takeuchi H, Kojima H, Yamamoto H et al, Evaluation of circulation profiles of lipsomes coated with hydrophillic polymers having different molecular weights in rats [J], J Control Release, 2001, 75:83-91.
29. Bailly S, Mahe Y, Bernard F et al. Ciprofloxacin diffrentially modulates IL-1α and IL-1β production[M]//Oppenheim J, Powanda MC, Kluger MJ, et al. Molecular and Cellular Biology of Cytokines. New York: Wiley-Liss Inc. 1990:93-98.
30. Staruch MJ, Wood DD. The adjuvanticity of interleukin 1 in vivo [J]. Int J Immunol, 1983, 130:2191-2194.
31. Durupinar B. The effect of drugs on the immune response [J]. Mikrobiyal Bul, 1987, 21:117-130.